These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
614 related articles for article (PubMed ID: 34391037)
1. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19. Jesuthasan A; Massey F; Manji H; Zandi MS; Wiethoff S J Neurol Sci; 2021 Sep; 428():117608. PubMed ID: 34391037 [TBL] [Abstract][Full Text] [Related]
2. The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use. McNett M; Fink EL; Schober M; Mainali S; Helbok R; Robertson CL; Mejia-Mantilla J; Kurtz P; Righy C; Roa JD; Villamizar-Rosales C; Altamirano V; Frontera JA; Maldonado N; Menon D; Suarez J; Chou SHY Neurocrit Care; 2020 Dec; 33(3):793-828. PubMed ID: 32948987 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies. Chong ZZ; Souayah N Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients. Chaumont H; Meppiel E; Roze E; Tressières B; de Broucker T; Lannuzel A; Rev Neurol (Paris); 2022; 178(1-2):137-143. PubMed ID: 35000793 [TBL] [Abstract][Full Text] [Related]
5. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER Front Immunol; 2022; 13():1070379. PubMed ID: 36591311 [TBL] [Abstract][Full Text] [Related]
8. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry. García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D; J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661 [TBL] [Abstract][Full Text] [Related]
9. European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. Crook H; Ramirez A; Hosseini A; Vavougyios G; Lehmann C; Bruchfeld J; Schneider A; D'Avossa G; Lo Re V; Salmoiraghi A; Mukaetova-Ladinska E; Katshu M; Boneschi FM; Håkansson K; Geerlings M; Pracht E; Ruiz A; Jansen JFA; Snyder H; Kivipelto M; Edison P Brain Connect; 2023 May; 13(4):178-210. PubMed ID: 36719785 [No Abstract] [Full Text] [Related]
10. [Update 2021: COVID-19 from the perspective of neurology]. Simon OJ; Menzler K; Timmermann L Dtsch Med Wochenschr; 2021 Jul; 146(13-14):918-923. PubMed ID: 34256409 [TBL] [Abstract][Full Text] [Related]
11. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). Harapan BN; Yoo HJ J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564 [TBL] [Abstract][Full Text] [Related]
12. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001 [TBL] [Abstract][Full Text] [Related]